PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 8 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
The chloroform-soluble fraction (CF) and n-hexane fraction (NHF) of leaf extracts exhibited antihyperglycemic properties in glucose tolerance tests [PMID:42041870].
Leaf extracts demonstrated analgesic effects on both central and peripheral pain [PMID:42041870].
Evidence summary
PubMed sources
- 1.PMID: 34676293 (2021) — The complete chloroplast genome of Ixora chinensis and phylogenetic relationships. · Mitochondrial DNA. Part B, Resources
- 2.PMID: 38807531 (2024) — Isolation, anticancer potency, and camptothecin-producing ability of endophytic fungi isolated from Ixora chinensis. · Science progress
- 3.PMID: 39650675 (2023) — Moderate photoinhibition of PSII and oxidation of P700 contribute to chilling tolerance of tropical tree species in subtropics of China. · Photosynthetica
- 4.PMID: 42041870 (2026) — GC-MS Guided Phytochemical Fingerprinting and Multi-Target Therapeutic Evaluation of Ixora chinensis Lam. Leaves: Insights into Its Hypoglycemic and Analgesic Activities. · Biology